×
About 1,251 results

ALLMedicine™ Breast Cancer Risk Factors Center

Research & Reviews  587 results

Gut microbiome, body weight, and mammographic breast density in healthy postmenopausal ...
https://doi.org/10.1007/s10552-021-01420-6 10.1146/annurev-genom-090711-163814 10.1172/JCI58109 10.1186/gm228 10.1038/nrmicro2974 10.1038/nrc3610 10.1158/1055-9965.EPI-06-0034 10.1148/radiology.188.2.8327668 10.1001/jama.1996.03540010035027 10.1148/radiol.2251011667 10.6004/jnccn.2010.0085 10.1155/2013/808317 10.1158/1055-9965.EPI-05-0479 10.3945/ajcn.112.034025 10.1093/jnci/84.14.1092 10.1177/0884533612454302 10.1080/01635581.2012.683227 10.1038/ejcn.2011.57 10.3945/jn.110.124313 10.1093/jn/136.2.466 10.1093/jnci/djk006 10.3945/ajcn.2009.27758 10.1007/s10552-010-9690-7 10.1053/j.gastro.2009.08.042 10.1126/science.1198719 10.1126/scitranslmed.3000322 10.1093/jnci/djt300 10.1097/CEJ.0000000000000310 10.1371/journal.pone.0216114 10.4161/cbt.3.4.779 10.1016/0010-7824(80)90120-1 10.1007/s10549-012-2185-3 10.7326/M14-1465 10.1186/s13058-017-0887-5 10.1093/jnci/95.7.556 10.1186/s13058-019-1110-7 10.1001/jama.285.2.171 10.1158/1055-9965.EPI-04-0327 10.1016/j.acra.2005.04.003 10.1371/journal.pone.0136667 10.1111/j.1524-4741.2012.01250.x 10.1016/j.breast.2004.12.004 10.1093/jnci/90.23.1801 10.2214/AJR.12.10197 10.1186/s12885-015-1256-3 10.1088/0031-9155/51/22/008 10.1259/bjr/14999231 10.2214/AJR.16.17525 10.7326/M17-3008 10.1007/s10552-020-01338-5 10.1128/AEM.65.11.4715-4724.1999 10.1128/AEM.64.10.3854-3859.1998 10.1038/nmeth.1184 10.1093/bib/bbr009 10.1093/nar/gkq872 10.1093/nar/gkr349 10.1038/nmeth.f.303 10.1007/s00248-013-0302-4 10.1128/AEM.00062-07 10.1093/oxfordjournals.aje.a113598 10.1056/NEJM198510243131703 10.4014/jmb.1709.09027 10.1128/mBio.01294-18 10.1200/JCO.2009.26.4770 10.1093/jnci/djk066 10.1093/jnci/djs327 10.1093/jnci/dju255 10.1080/01635581.2012.707279 10.1186/bcr3432 10.1016/j.cell.2014.03.011 10.1002/art.39259 10.1038/nri3430 10.1158/1055-9965.EPI-07-2836 10.1007/s10549-007-9829-8 10.1007/s10549-010-1249-5 10.1038/nature05414 10.1016/j.chom.2008.02.015 10.1038/nature07540 10.1111/j.1365-2362.2012.02659.x 10.1093/jnci/djv088 10.1093/bfgp/elt014 10.1186/s12982-015-0044-5 10.1093/jnci/87.17.1297 10.1093/jnci/93.9.710 10.1038/sj.bjc.6602313 10.1093/aje/kwi087 10.1016/j.jfma.2018.07.009 10.1016/j.chom.2017.10.005 10.1126/science.aav6870 10.1126/science.aac6468 10.1186/bcr3141 10.1186/s12943-015-0291-7 10.1677/erc.1.01150 10.1016/S1470-2045(10)70095-4 10.1093/annonc/mdt207 10.1002/ijc.24674 10.3390/microorganisms7010014 10.1111/1462-2920.13463 10.1007/s13668-018-0248-8 10.1186/s40168-017-0258-6 10.1128/mSystems.00130-17 10.1038/s41598-018-22438-y 10.3389/fmicb.2016.00979 10.3748/wjg.v17.i12.1519 10.1158/1055-9965.EPI-07-0559 10.1186/s12915-019-0699-4 10.1158/1055-9965.EPI-16-0499 10.1186/s13058-019-1198-9 10.1128/IAI.01520-08 10.1186/gb-2011-12-5-r50 10.1038/nature11234 10.1126/science.1237439 10.1073/pnas.1319284111 10.1093/jnci/djw128 10.1186/1471-2288-13-38 10.1093/ageing/afq038 10.1017/S1368980011003193 10.1079/PHN2001322 10.1371/journal.pone.0231229
Cancer Causes & Control : CCC; Yaghjyan L, Mai V et. al.

Mar 27th, 2021 - We examined gut microbiome (GM) profiles in relation to mammographic breast density (BD) and body mass index (BMI) in healthy postmenopausal women. Eligible women were postmenopausal, had a BMI ≤ 35 kg/m2, and had not recently taken oral/IV antibi...

Incidental Pathologic Findings in Young Adult Reduction Mammaplasty.
https://doi.org/10.1097/PRS.0000000000007609
Plastic and Reconstructive Surgery; Maroney J, Collins KC et. al.

Feb 23rd, 2021 - This study aims to characterize incidental microscopic findings in this population to determine whether there is a benefit to routine histopathologic examination of breast tissue in young women. A retrospective review of young women who underwent ...

Antiplatelet Drug Use and Breast Cancer Risk in a Prospective Cohort of Postmenopausal ...
https://doi.org/10.1158/1055-9965.EPI-20-1292
Cancer Epidemiology, Biomarkers & Prevention : a Publicat... Cairat M, Al Rahmoun M et. al.

Feb 3rd, 2021 - Epidemiologic evidence is insufficient to draw conclusions on the impact of low-dose aspirin use on breast cancer risk, and the potential impact of other antiplatelet drugs such as clopidogrel needs to be explored. We investigated the association ...

Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Brea...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026532
Cancer Epidemiology, Biomarkers & Prevention : a Publicat... Morra A, Jung AY et. al.

Jan 27th, 2021 - It is not known whether modifiable lifestyle factors that predict survival after invasive breast cancer differ by subtype. We analyzed data for 121,435 women diagnosed with breast cancer from 67 studies in the Breast Cancer Association Consortium ...

Breast cancer risk factors by mode of detection among screened women in the Cancer Prev...
https://doi.org/10.1007/s10549-020-06025-2 10.1093/jnci/djx001
Breast Cancer Research and Treatment; Gaudet MM, Deubler E et. al.

Jan 5th, 2021 - Identifying risk factors for women at high risk of symptom-detected breast cancers that were missed by screening would enable targeting of enhanced screening regimens. To this end, we examined associations of breast cancer risk factors by mode of ...

see more →

Guidelines  13 results

Breast cancer risk factors and their effects on survival: a Mendelian randomisation study
https://pubmed.ncbi.nlm.nih.gov/33198768/
BMC Medicine; Escala-Garcia M

Nov 16th, 2020 - Observational studies have investigated the association of risk factors with breast cancer prognosis. However, the results have been conflicting and it has been challenging to establish causality due to potential residual confounding. Using a Mend...

Breast Cancer Risk Factors - breastcancer.org
https://www.breastcancer.org/risk/factors

May 31st, 2019 - Every woman wants to know what she can do to lower her risk of breast cancer. Some of the factors associated with breast cancer -- being a woman, your age, and your genetics, for example -- can't be changed. Other factors -- being overweight, lack...

Breast Cancer: Medication Use to Reduce Risk- Draft Recommendation Statement
https://www.uspreventiveservicestaskforce.org/Page/Document/draft-recommendation-statement/breast-cancer-medications-for-risk-reduction1
USPSTF

Jan 14th, 2019 - The USPSTF concludes with moderate certainty that there is a moderate net benefit from taking tamoxifen, raloxifene, or aromatase inhibitors to reduce risk of invasive breast cancer in women at increased risk. The USPSTF concludes with moderate ce...

BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors
https://www.nature.com/articles/s41436-018-0406-9
Lee,A.,et al

Jan 14th, 2019 - Breast cancer (BC) risk prediction allows systematic identification of individuals at highest and lowest risk. We extend the Breast and Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm (BOADICEA) risk model to incorporate the...

Circulating anti‐Müllerian hormone and breast cancer risk: A study in ten prospective cohorts
https://onlinelibrary.wiley.com/doi/10.1002/ijc.31249
Ge,W.,et al

Jan 7th, 2019 - A strong positive association has been observed between circulating anti‐Müllerian hormone (AMH), a biomarker of ovarian reserve, and breast cancer risk in three prospective studies. Confirming this association is important because of the paucity ...

see more →

Clinicaltrials.gov  623 results

Gut microbiome, body weight, and mammographic breast density in healthy postmenopausal ...
https://doi.org/10.1007/s10552-021-01420-6 10.1146/annurev-genom-090711-163814 10.1172/JCI58109 10.1186/gm228 10.1038/nrmicro2974 10.1038/nrc3610 10.1158/1055-9965.EPI-06-0034 10.1148/radiology.188.2.8327668 10.1001/jama.1996.03540010035027 10.1148/radiol.2251011667 10.6004/jnccn.2010.0085 10.1155/2013/808317 10.1158/1055-9965.EPI-05-0479 10.3945/ajcn.112.034025 10.1093/jnci/84.14.1092 10.1177/0884533612454302 10.1080/01635581.2012.683227 10.1038/ejcn.2011.57 10.3945/jn.110.124313 10.1093/jn/136.2.466 10.1093/jnci/djk006 10.3945/ajcn.2009.27758 10.1007/s10552-010-9690-7 10.1053/j.gastro.2009.08.042 10.1126/science.1198719 10.1126/scitranslmed.3000322 10.1093/jnci/djt300 10.1097/CEJ.0000000000000310 10.1371/journal.pone.0216114 10.4161/cbt.3.4.779 10.1016/0010-7824(80)90120-1 10.1007/s10549-012-2185-3 10.7326/M14-1465 10.1186/s13058-017-0887-5 10.1093/jnci/95.7.556 10.1186/s13058-019-1110-7 10.1001/jama.285.2.171 10.1158/1055-9965.EPI-04-0327 10.1016/j.acra.2005.04.003 10.1371/journal.pone.0136667 10.1111/j.1524-4741.2012.01250.x 10.1016/j.breast.2004.12.004 10.1093/jnci/90.23.1801 10.2214/AJR.12.10197 10.1186/s12885-015-1256-3 10.1088/0031-9155/51/22/008 10.1259/bjr/14999231 10.2214/AJR.16.17525 10.7326/M17-3008 10.1007/s10552-020-01338-5 10.1128/AEM.65.11.4715-4724.1999 10.1128/AEM.64.10.3854-3859.1998 10.1038/nmeth.1184 10.1093/bib/bbr009 10.1093/nar/gkq872 10.1093/nar/gkr349 10.1038/nmeth.f.303 10.1007/s00248-013-0302-4 10.1128/AEM.00062-07 10.1093/oxfordjournals.aje.a113598 10.1056/NEJM198510243131703 10.4014/jmb.1709.09027 10.1128/mBio.01294-18 10.1200/JCO.2009.26.4770 10.1093/jnci/djk066 10.1093/jnci/djs327 10.1093/jnci/dju255 10.1080/01635581.2012.707279 10.1186/bcr3432 10.1016/j.cell.2014.03.011 10.1002/art.39259 10.1038/nri3430 10.1158/1055-9965.EPI-07-2836 10.1007/s10549-007-9829-8 10.1007/s10549-010-1249-5 10.1038/nature05414 10.1016/j.chom.2008.02.015 10.1038/nature07540 10.1111/j.1365-2362.2012.02659.x 10.1093/jnci/djv088 10.1093/bfgp/elt014 10.1186/s12982-015-0044-5 10.1093/jnci/87.17.1297 10.1093/jnci/93.9.710 10.1038/sj.bjc.6602313 10.1093/aje/kwi087 10.1016/j.jfma.2018.07.009 10.1016/j.chom.2017.10.005 10.1126/science.aav6870 10.1126/science.aac6468 10.1186/bcr3141 10.1186/s12943-015-0291-7 10.1677/erc.1.01150 10.1016/S1470-2045(10)70095-4 10.1093/annonc/mdt207 10.1002/ijc.24674 10.3390/microorganisms7010014 10.1111/1462-2920.13463 10.1007/s13668-018-0248-8 10.1186/s40168-017-0258-6 10.1128/mSystems.00130-17 10.1038/s41598-018-22438-y 10.3389/fmicb.2016.00979 10.3748/wjg.v17.i12.1519 10.1158/1055-9965.EPI-07-0559 10.1186/s12915-019-0699-4 10.1158/1055-9965.EPI-16-0499 10.1186/s13058-019-1198-9 10.1128/IAI.01520-08 10.1186/gb-2011-12-5-r50 10.1038/nature11234 10.1126/science.1237439 10.1073/pnas.1319284111 10.1093/jnci/djw128 10.1186/1471-2288-13-38 10.1093/ageing/afq038 10.1017/S1368980011003193 10.1079/PHN2001322 10.1371/journal.pone.0231229
Cancer Causes & Control : CCC; Yaghjyan L, Mai V et. al.

Mar 27th, 2021 - We examined gut microbiome (GM) profiles in relation to mammographic breast density (BD) and body mass index (BMI) in healthy postmenopausal women. Eligible women were postmenopausal, had a BMI ≤ 35 kg/m2, and had not recently taken oral/IV antibi...

Incidental Pathologic Findings in Young Adult Reduction Mammaplasty.
https://doi.org/10.1097/PRS.0000000000007609
Plastic and Reconstructive Surgery; Maroney J, Collins KC et. al.

Feb 23rd, 2021 - This study aims to characterize incidental microscopic findings in this population to determine whether there is a benefit to routine histopathologic examination of breast tissue in young women. A retrospective review of young women who underwent ...

Antiplatelet Drug Use and Breast Cancer Risk in a Prospective Cohort of Postmenopausal ...
https://doi.org/10.1158/1055-9965.EPI-20-1292
Cancer Epidemiology, Biomarkers & Prevention : a Publicat... Cairat M, Al Rahmoun M et. al.

Feb 3rd, 2021 - Epidemiologic evidence is insufficient to draw conclusions on the impact of low-dose aspirin use on breast cancer risk, and the potential impact of other antiplatelet drugs such as clopidogrel needs to be explored. We investigated the association ...

Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Brea...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026532
Cancer Epidemiology, Biomarkers & Prevention : a Publicat... Morra A, Jung AY et. al.

Jan 27th, 2021 - It is not known whether modifiable lifestyle factors that predict survival after invasive breast cancer differ by subtype. We analyzed data for 121,435 women diagnosed with breast cancer from 67 studies in the Breast Cancer Association Consortium ...

Breast cancer risk factors by mode of detection among screened women in the Cancer Prev...
https://doi.org/10.1007/s10549-020-06025-2 10.1093/jnci/djx001
Breast Cancer Research and Treatment; Gaudet MM, Deubler E et. al.

Jan 5th, 2021 - Identifying risk factors for women at high risk of symptom-detected breast cancers that were missed by screening would enable targeting of enhanced screening regimens. To this end, we examined associations of breast cancer risk factors by mode of ...

see more →

News  27 results

Breast cancer risk factors and their effects on survival: a Mendelian randomisation study
https://pubmed.ncbi.nlm.nih.gov/33198768/
BMC Medicine; Escala-Garcia M

Nov 16th, 2020 - Observational studies have investigated the association of risk factors with breast cancer prognosis. However, the results have been conflicting and it has been challenging to establish causality due to potential residual confounding. Using a Mend...

Women Can Take Charge of Certain Breast Cancer Risk Factors
https://www.medscape.com/viewarticle/919316

Oct 1st, 2019 - CHICAGO — "In medical school, we focus on pathophysiology and mechanisms and medicines and treatments, and not so much on lifestyle" when it comes to breast cancer, said Jewel Kling, MD, from Women's Health Internal Medicine in Scottsdale, Arizona...

Breast Cancer Risk Factors - breastcancer.org
https://www.breastcancer.org/risk/factors

May 31st, 2019 - Every woman wants to know what she can do to lower her risk of breast cancer. Some of the factors associated with breast cancer -- being a woman, your age, and your genetics, for example -- can't be changed. Other factors -- being overweight, lack...

Breast Cancer: Medication Use to Reduce Risk- Draft Recommendation Statement
https://www.uspreventiveservicestaskforce.org/Page/Document/draft-recommendation-statement/breast-cancer-medications-for-risk-reduction1
USPSTF

Jan 14th, 2019 - The USPSTF concludes with moderate certainty that there is a moderate net benefit from taking tamoxifen, raloxifene, or aromatase inhibitors to reduce risk of invasive breast cancer in women at increased risk. The USPSTF concludes with moderate ce...

BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors
https://www.nature.com/articles/s41436-018-0406-9
Lee,A.,et al

Jan 14th, 2019 - Breast cancer (BC) risk prediction allows systematic identification of individuals at highest and lowest risk. We extend the Breast and Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm (BOADICEA) risk model to incorporate the...

see more →

Patient Education  1 results see all →